Stereotaxis (STXS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Stereotaxis (STXS) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.56 of bullish evidence against -0.36 bearish.

Stereotaxis last closed at $1.15, -2.54% on the session.

Against the IVW growth benchmark the position is -3.15% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

17 graded predictions for STXS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Stereotaxis in the 5th percentile on return on equity, where 100 is best.

Stereotaxis is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $118.24M.

StockMap tracks Stereotaxis as the 100th largest of the 136 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 74 Neutral, 56 Moderate Underperform, 5 Strong Underperform and 1 Moderate Outperform.

On that composite Stereotaxis ranks 113th of 136 in the group, against a group median of -0.18.